PTCL Study - PD-1 blockade with pembrolizumab in relapsed/refractory mature T-cell and NK-cell lymphomas

View Statistics Email Alert RSS Feed

Grant Data
Project Title
PTCL Study - PD-1 blockade with pembrolizumab in relapsed/refractory mature T-cell and NK-cell lymphomas
Principal Investigator
Professor Tse, Eric Wai Choi   (Principal Investigator (PI))
Co-Investigator(s)
Dr Hwang Yu Yan   (Co-Investigator)
Professor Kwong Yok Lam   (Co-Investigator)
Dr Chan Sau Yan Thomas   (Co-Investigator)
Duration
60
Start Date
2017-06-28
Completion Date
2022-06-27
Amount
5141132
Conference Title
PTCL Study - PD-1 blockade with pembrolizumab in relapsed/refractory mature T-cell and NK-cell lymphomas
Keywords
NK-cell lymphomas, PD-1 blockade with pembrolizumab, relapsed/refractory mature T-cell
Discipline
Cancer
HKU Project Code
AR170037
Grant Type
Merck, Sharp and Dohme (Asia) Ltd. - General Award
Funding Year
2016
Status
Completed
Objectives
Refer to hard copy of the project.